Drug-induced liver injury and aspects application of hepatoprotectors in practical medicine

In the last decade, there has been an increase in the number of side effects and complications of drug therapy all over the world, among which the drug-induced liver injury (LS1) constitutes the majority (1). To a large extent, this is due to the liberalization of the population's access to medicines, as well as the aggressive advertising activities of some pharmaceutical manufacturers. The consequence of this was an increase in the number of P11 in a variety of categories of patients and even pregnant women.